Skip to main content
. 2022 Feb 25;15(3):287. doi: 10.3390/ph15030287

Figure 9.

Figure 9

The diagram illustrating the effects and mechanisms of inhibiting the early response cytokines tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and/or interleukin-6 (IL-6) (as achieved by the novel peptides KCF18 and SEM18) on inhibiting endotoxin-induced lung injury in the early phase of endotoxemia (i.e., 24 h after endotoxemia induction) in mice.